COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus

ConditionsNeonatal Hypoglycemia Gestational Diabetes Mellitus (GDM)

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age1-30

SponsorInstitute of Mother and Child, Warsaw, Poland

About this trial

The purpose of this study is to determine whether continuous glucose monitoring (CGM) improves the detection and management of neonatal hypoglycaemia in newborns of mothers with insulin-treated gestational diabetes.

Eligibility criteria

Qualifiers

Maternal age of 18 years or older

Singleton pregnancy

Insulin-treated gestational diabetes mellitus

Disqualifiers

Multifetal pregnancy

Congenital malformations or metabolic defects in the newborn

Preterm birth (defined as birth <37 weeks of gestation)

Smoking during pregnancy

Trial design

Treatments tested in this trial

Dexcom ONE Continuous Glucose Monitoring System

Treatment groups

120 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Institute of Mother and Child, Warsaw, Poland

Lead sponsor

Source ClinicalTrials.gov